Amneal Pharmaceuticals, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1292740,
    "name": "Amneal Pharmaceuticals, Inc.",
    "stock_name": "Amneal Pharmaceuticals, Inc.",
    "full_name": "Amneal Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/amneal-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "12.87",
    "chg": 0.05,
    "chgp": "0.39%",
    "dir": 1,
    "prev_price": "12.82",
    "mcapval": "3,055.99",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03168L1052",
    "curr_date": "Dec 24",
    "curr_time": "",
    "bse_nse_vol": "1.63 M",
    "exc_status": "Active",
    "traded_date": "Dec 24, 2025",
    "traded_date_str": "2025 12 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amneal-pharmaceuticals-inc-1292740-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Amneal Pharmaceuticals Hits New 52-Week High of $10.70",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amneal-pharmaceuticals-hits-new-52-week-high-of-1070-3662059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AmnealPharmaceu_priceRelatedfactors_3662059.png",
        "date": "2025-10-31 16:34:46",
        "description": "Amneal Pharmaceuticals, Inc. achieved a new 52-week high of USD 10.70 on October 30, 2025, reflecting a 45.99% growth over the past year. The company, with a market capitalization of USD 3,056 million, operates in the Pharmaceuticals & Biotechnology industry and exhibits unique financial metrics."
      },
      {
        "title": "Amneal Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amneal-pharmaceuticals-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-price-gains-3601462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AmnealPharmaceu_technicaldot_3601462.png",
        "date": "2025-10-07 21:20:15",
        "description": "Amneal Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The company’s stock price has shown resilience, with a notable year-to-date return of 33.21%. Over the past year, it has outperformed the S&P 500, reflecting its strong recovery and growth trajectory in the pharmaceuticals sector."
      },
      {
        "title": "Is Amneal Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-amneal-pharmaceuticals-inc-technically-bullish-or-bearish-3599411",
        "imagepath": "",
        "date": "2025-10-07 12:26:23",
        "description": "As of 3 October 2025, the technical trend for Amneal Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. Bollinger Bands also indicate a bullish stance on both weekly and monthly time frames. However, the weekly RSI is bearish, suggesting some short-term weakness, while the monthly RSI shows no signal. The daily moving averages are bullish, reinforcing the overall positive outlook. Dow Theory indicates a mildly bullish trend on the monthly chart, with no trend on the weekly. Additionally, the KST is bullish weekly but mildly bearish monthly, and the OBV shows a mildly bullish stance monthly.\n\nIn terms of performance, Amneal has outperformed the S&P 500 across all multi-period returns, notably with a 375.23% return over three years compared to the S&P 500's 82.57%. Overall, the current technical stance is bu..."
      },
      {
        "title": "Amneal Pharmaceuticals Hits New 52-Week High of $10.67",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amneal-pharmaceuticals-hits-new-52-week-high-of-1067-3595701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AmnealPharmaceu_priceRelatedfactors_3595701.png",
        "date": "2025-10-06 17:46:45",
        "description": "Amneal Pharmaceuticals, Inc. achieved a new 52-week high of USD 10.67 on October 3, 2025, reflecting a 51.68% growth over the past year. The company, with a market capitalization of USD 3,056 million, faces challenges such as negative return on equity and a significant debt-to-equity ratio."
      },
      {
        "title": "Is Amneal Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-amneal-pharmaceuticals-inc-technically-bullish-or-bearish-3592214",
        "imagepath": "",
        "date": "2025-10-05 12:02:13",
        "description": "As of 3 October 2025, the technical trend for Amneal Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, supported by bullish signals in the MACD (both weekly and monthly), Bollinger Bands (weekly and monthly), and daily moving averages. However, the weekly RSI is bearish, indicating some short-term weakness. The KST is bullish on a weekly basis but mildly bearish monthly, while Dow Theory and OBV show a mildly bullish stance on both time frames. \n\nIn terms of performance, Amneal has outperformed the S&P 500 across multiple periods, with a year-to-date return of 31.19% compared to the S&P 500's 14.18%, and an impressive 399.52% return over the last three years versus the S&P 500's 82.57%...."
      },
      {
        "title": "Amneal Pharmaceuticals Hits New 52-Week High of $10.43",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amneal-pharmaceuticals-hits-new-52-week-high-of-1043-3588440",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AmnealPharmaceu_priceRelatedfactors_3588440.png",
        "date": "2025-10-02 22:45:18",
        "description": "Amneal Pharmaceuticals, Inc. achieved a new 52-week high of USD 10.43 on October 1, 2025, reflecting a significant increase from its previous low. The company has seen a 51.53% rise in stock price over the past year, outperforming the S&P 500, and has a market capitalization of USD 3,056 million."
      }
    ],
    "total": 10,
    "sid": "1292740",
    "stock_news_url": "https://www.marketsmojo.com/news/amneal-pharmaceuticals-inc-1292740"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Amneal Pharmaceuticals Hits New 52-Week High of $10.70

2025-10-31 16:34:46

Amneal Pharmaceuticals, Inc. achieved a new 52-week high of USD 10.70 on October 30, 2025, reflecting a 45.99% growth over the past year. The company, with a market capitalization of USD 3,056 million, operates in the Pharmaceuticals & Biotechnology industry and exhibits unique financial metrics.

Amneal Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-10-07 21:20:15

Amneal Pharmaceuticals, Inc. has recently revised its evaluation amid changing market conditions. The company’s stock price has shown resilience, with a notable year-to-date return of 33.21%. Over the past year, it has outperformed the S&P 500, reflecting its strong recovery and growth trajectory in the pharmaceuticals sector.

Is Amneal Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-07 12:26:23

As of 3 October 2025, the technical trend for Amneal Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. Bollinger Bands also indicate a bullish stance on both weekly and monthly time frames. However, the weekly RSI is bearish, suggesting some short-term weakness, while the monthly RSI shows no signal. The daily moving averages are bullish, reinforcing the overall positive outlook. Dow Theory indicates a mildly bullish trend on the monthly chart, with no trend on the weekly. Additionally, the KST is bullish weekly but mildly bearish monthly, and the OBV shows a mildly bullish stance monthly. In terms of performance, Amneal has outperformed the S&P 500 across all multi-period returns, notably with a 375.23% return over three years compared to the S&P 500's 82.57%. Overall, the current technical stance is bu...

Amneal Pharmaceuticals Hits New 52-Week High of $10.67

2025-10-06 17:46:45

Amneal Pharmaceuticals, Inc. achieved a new 52-week high of USD 10.67 on October 3, 2025, reflecting a 51.68% growth over the past year. The company, with a market capitalization of USD 3,056 million, faces challenges such as negative return on equity and a significant debt-to-equity ratio.

Is Amneal Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-05 12:02:13

As of 3 October 2025, the technical trend for Amneal Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, supported by bullish signals in the MACD (both weekly and monthly), Bollinger Bands (weekly and monthly), and daily moving averages. However, the weekly RSI is bearish, indicating some short-term weakness. The KST is bullish on a weekly basis but mildly bearish monthly, while Dow Theory and OBV show a mildly bullish stance on both time frames. In terms of performance, Amneal has outperformed the S&P 500 across multiple periods, with a year-to-date return of 31.19% compared to the S&P 500's 14.18%, and an impressive 399.52% return over the last three years versus the S&P 500's 82.57%....

Amneal Pharmaceuticals Hits New 52-Week High of $10.43

2025-10-02 22:45:18

Amneal Pharmaceuticals, Inc. achieved a new 52-week high of USD 10.43 on October 1, 2025, reflecting a significant increase from its previous low. The company has seen a 51.53% rise in stock price over the past year, outperforming the S&P 500, and has a market capitalization of USD 3,056 million.

View All News